- Aflibercept in terms of ophthalmology2014 | First Faculty of Medicine
- Aflibercept in the treatment of metastatic colorectal cancer2014 | Second Faculty of Medicine
- Aflibercept in the Diabetic Macular Edema Treatment2015 | Faculty of Medicine in Hradec Králové
- One-year follow-up outcomes of the treatment of wet age-related macular degeneration with aflibercept2018 | Third Faculty of Medicine
- Aflibercept for Vascularised Serous Pigment Epithelial Detachment: One-Year Anatomical and Functional Results2020 | First Faculty of Medicine
- Aflibercept for patients with metastatic colorectal cancerPublication without faculty affiliation
- Effect of baseline central retinal thickness on the results of treatment of diabetic macular edema with aflibercept: real-life evidence in the Czech republic2022 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Efficacy of anti-VEGF therapy (aflibercept) in advanced colorectal cancer2019 | Publication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. RTH258-C002Publication without faculty affiliation
- Complete remission during FOLFIRI + aflibercept (Zaltrap) treatment in patient with liver and lung metastasis from colorectal cancer2019 | Third Faculty of Medicine
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. BAY 86-5321/16598Publication without faculty affiliation
- Efficacy of anti-VEGF therapy with afliberceptem in advanced colorectal cancer2017 | Publication without faculty affiliation
- The diabetic macular edema - new possibilities of the treatment2012 | Faculty of Medicine in Hradec Králové
- Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy2015 | Publication without faculty affiliation
- Observed benefit and safety of aflibercept in elderly patients with metastatic colorectal cancer: An age-based analysis from the randomized placebo-controlled phase III VELOUR trial2018 | Publication without faculty affiliation
- Use of anti-VEGF drugs in ophthalmology2019 | Faculty of Medicine in Hradec Králové
- Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial2014 | Second Faculty of Medicine
- Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration: A Phase 3 Randomized Clinical Trial2023 | Third Faculty of Medicine, Central Library of Charles University
- Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial2022 | Publication without faculty affiliation
- Safety and effectiveness of aflibercept + fluorouracil, leucovorin, and irinotecan (FOLFIRI) for the treatment of patients with metastatic colorectal cancer (mCRC) in current clinical practice: OZONE study2020 | Publication without faculty affiliation
- Komentář ke studii: Sledování biomarkerů ve studii VELOUR - vliv mutací RAS, BRAF a lokalizace nádoru na účinnost léčby afliberceptem2018 | Publication without faculty affiliation
- Age-related macular degeneration Age-related macular degeneration2021 | Faculty of Medicine in Hradec Králové
- Age-related macular degeneration - current pharmacotherapy in the Czech Republic2016 | First Faculty of Medicine
- Two-year results of a combined regimen of aflibercept treatment in three types of choroidal neovascular membrane in the wet form of age-related macular degeneration: Real-life evidence in the Czech Republic2021 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Sequential Treatment with Bevacizumab and Aflibercept for Metastatic Colorectal Cancer in Real-World Clinical Practice2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Physical Education and Sport
- Diabetic macular edema from the point of view of an ophthalmologist and a diabetologist2013 | Faculty of Medicine in Hradec Králové
- Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen2012 | Second Faculty of Medicine
- Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials2022 | Publication without faculty affiliation
- Intravitreálně podávané léky v léčbě diabetického makulárního edému2015 | Faculty of Medicine in Hradec Králové
- Response to Aflibercept Therapy in Three Types of Choroidal Neovascular Membrane in Neovascular Age-Related Macular Degeneration: Real-Life Evidence in the Czech Republic2019 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine